LCM

Lynx1 Capital Management Portfolio holdings

AUM $346M
1-Year Est. Return 2.97%
This Quarter Est. Return
1 Year Est. Return
-2.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$117M
AUM Growth
+$9.68M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
15
New
Increased
Reduced
Closed

Top Buys

1
+$12.4M
2
+$3.9M
3
+$3.83M
4
ALPN
Alpine Immune Sciences Inc
ALPN
+$3.76M
5
CBAY
Cymabay Therapeutics
CBAY
+$3.54M

Top Sells

1
+$10.6M
2
+$7.35M
3
+$185K
4
ELEV
Elevation Oncology
ELEV
+$25K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$26.2M 22.29%
2,831,588
-20,000
2
$22.7M 19.31%
1,001,217
+107,690
3
$21.1M 17.99%
1,674,677
+982,169
4
$16.4M 13.97%
1,926,869
+442,176
5
$7.64M 6.51%
2,589,679
+1,201,174
6
$6.69M 5.7%
2,180,560
+537,726
7
$6.03M 5.14%
40,292
+26,088
8
$3.83M 3.26%
+1,104,241
9
$2.99M 2.55%
5,473
+3,559
10
$2.79M 2.38%
504,862
+148,035
11
$995K 0.85%
21,071
+15,796
12
$62K 0.05%
30,000
13
– –
-411,680
14
– –
-1,543,259
15
– –
-10,000